A retrospective study including more than 350,000 women, about 1400 of whom had 
developed meningioma, showed that the risk of meningioma was about twice as high 
in users of postmenopausal hormone replacement therapy as in non-users. Hormone 
replacement therapy should be discontinued if meningioma is diagnosed.